Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels

MLA

Masataka Shinozaki, et al. “Hypoprolactinemia and Hyperprolactinemia in Male Schizophrenia Patients Treated with Aripiprazole and Risperidone and Their Relationships with Testosterone Levels.” Neuropsychopharmacology Reports, vol. 41, June 2021, pp. 379–84. EBSCOhost, https://doi.org/10.1002/npr2.12190.

APA

Masataka Shinozaki, Saaya Yokoyama, Norio Yasui-Furukori, Norio Sugawara, Minami Tasaki, & Kazutaka Shimoda. (2021). Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels. Neuropsychopharmacology Reports, 41, 379–384. https://doi.org/10.1002/npr2.12190

Chicago

Masataka Shinozaki, Saaya Yokoyama, Norio Yasui-Furukori, Norio Sugawara, Minami Tasaki, and Kazutaka Shimoda. 2021. “Hypoprolactinemia and Hyperprolactinemia in Male Schizophrenia Patients Treated with Aripiprazole and Risperidone and Their Relationships with Testosterone Levels.” Neuropsychopharmacology Reports 41 (June): 379–84. doi:10.1002/npr2.12190.